US POINTER: a structured lifestyle program improved cognition

US POINTER, the large American replication of Europe’s FINGER trial, reported in JAMA on July 28, 2025: a 2-year randomized trial in 2,111 at-risk older adults (ages 60 to 79) testing a multidomain lifestyle program of exercise, a MIND-style diet, cognitive and social engagement, and regular vascular monitoring. Both arms got the program. The difference was how it was delivered: a structured arm with 38 facilitated team meetings and coaching, versus a self-guided arm with light encouragement and materials.

Global cognition improved in both arms, and the structured arm improved more (an advantage of about 0.03 SD per year, p = .008). The headline is less the effect size than the design lesson: structure and accountability beat going it alone.

Why this matters for a carrier: the trial deliberately enrolled the cardiometabolic-risk, family-history profile many APOE4 carriers share, so it speaks directly to the population that most wants to act. It reinforces that the levers work better with a system around them.

The honest caveat: these are 2-year cognitive outcomes in people who were cognitively healthy at the start, and both arms were active, so this is structured versus self-guided, not lifestyle versus nothing. It does not prove dementia prevention.

Full treatment in our deep dive on US POINTER and lifestyle, with the European FINGER trial for context. Primary source: JAMA, 2025. This is education, not medical advice.